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Abstract
Background: A solitary fibrous tumour is a rare, mainly benign spindle cell mesenchymal tumour most commonly
originating from the pleura. An intrapericardial location of a solitary fibrous tumour is extremely unusual. We present a
case of an asymptomatic patient with a slow-growing massive benign cardiac solitary fibrous tumour.
Case presentation: A 37-year-old asymptomatic female patient was referred to our hospital with an enlarged cardiac
silhouette found on her screening chest X-ray. The echocardiographic examination revealed pericardial effusion and an
inhomogeneous mobile mass located in the pericardial sac around the left ventricle. Cardiac magnetic resonance (MRI)
examination showed an intrapericardial, semilunar-shaped mass attached to the pulmonary trunk with an intermediate
signal intensity on proton density-weighted images and high signal intensity on T2-weighted spectral fat saturation
inversion recovery images. First-pass perfusion and early and late gadolinium-enhanced images showed a vascularized
mass with septated, patchy, inhomogeneous late enhancement. Coronary computed tomography angiography revealed
no invasion of the coronaries. Based on the retrospectively analysed screening chest X-rays, the mass had started
to form at least 7 years earlier. Complete resection of the tumour with partial resection of the pulmonary trunk
was performed. Histological evaluation of the septated, cystic mass revealed tumour cells forming an irregular
patternless pattern; immunohistochemically, the cells tested positive for vimentin, CD34, CD99 and STAT6 but
negative for keratin (AE1-AE3), CD31 and S100. Thus, the diagnosis of an intrapericardial solitary fibrous tumour
was established. There has been no recurrence for 3 years based on the regular MRI follow-up.
Conclusion: Intrapericardial SFTs, showing slow growth dynamics, can present with massive extent even in completely
asymptomatic patients. MRI is exceedingly useful for characterizing intrapericardial masses, allowing precise surgical
planning, and is reliable for long-term follow up.
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Background
A solitary fibrous tumour (SFT) is a rare primary
tumour most commonly originating from mesenchy-
mal tissue of the pleura. Complete surgical resection
is the main treatment if possible. Histological appear-
ance shows spindle-shaped cells and collagen fibres.
Immunohistochemical features are vimentin, CD34,
CD99 positivity and S-100 protein negativity [1]. Al-
though the majority of SFTs generally exhibit clinic-
ally benign behaviour, 10–30% of SFTs have been
associated with local recurrence or histologic malig-
nancy [2, 3]. We have only limited data regarding the
manifestation and behaviour of rare extrapleural
forms such as cardiac SFT [4].
Case presentation
A 37-year-old asymptomatic female patient was referred
to our hospital with an enlarged cardiac silhouette
found on her screening chest X-ray (Fig. 1, panel d).
She had no history of cardiovascular disease. She had a
spontaneous abortion 3 years previously, and she is a
mother of three children. She has a positive family his-
tory of cardiovascular diseases and cancer (lung adeno-
carcinoma and brain tumour). Physical examination
revealed distant heart sounds, a regular rate and
rhythm. The echocardiographic examination revealed
pericardial effusion and an inhomogeneous mobile
mass located in the pericardial sac around the left ven-
tricle (Fig. 2, Additional file 1). Subsequently, cardiac
magnetic resonance imaging (MRI) was performed,
which showed an intrapericardial, semilunar-shaped
mass with a size of 10 × 4 × 9 cm attached to the pul-
monary trunk surrounding the aortic root, left atrium
and left ventricle (Fig. 3). The tumour had well-
demarcated margins and did not invade the blood ves-
sels or myocardium. The caudal part of the tumour was
mobile, while its cranial part was fixed to the pulmon-
ary trunk (Additional file 2). The MRI scan detected
intermediate signal intensity on proton density-weighted
images and high signal intensity on T2-weighted spec-
tral fat saturation inversion recovery (SPIR) images
(Fig. 3, panel e, f ). Both first-pass perfusion and early
and late gadolinium-enhanced (LGE) images showed
that the mass was vascularized and showed septated,
patchy, inhomogeneous LGE (Fig. 3, panel g, h). Cor-
onary computed tomography angiography (CTA) was
performed to see whether the coronary arteries were
affected. The coronary CTA proved that coronaries
were not invaded by the tumour (Fig. 4). We have
evaluated the previous screening chest X-rays of the
patient that were acquired during the past 10 years.
Fig. 1 Chest X-ray examinations performed in 2004 (panel a), 2007 (panel b), 2010 (panel c) and in 2014 (panel d). Arrows show the enlarged
cardiac silhouette
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Fig. 3 Cine movie MRI images in the long- (panel a, b) and short-axis planes in diastolic phase (panel c and d). Intermediate signal intensity on
proton density-weighted images (panel e) and high signal intensity on T2-weighted SPIR images (panel f). LGE images in the long- (panel g) and
short-axis planes (panel h). Arrows show the intrapericardial tumour
Fig. 2 Transthoracic 2D echocardiography in the parasternal long-axis plane (panel a), short-axis plane (panel b) and apical four-chamber view
(panel c). Arrows show the intrapericardial mass
Fig. 4 Coronary CTA images (panel a: axial plane, panel b: two-chamber view reconstruction) showed that coronary arteries were not invaded by
the tumour. Arrows show the left anterior descending artery
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Based on these chest X-rays, we can conclude that
the mass had started to form at least 7 years ago
(Fig. 1). No abnormalities were found by the ab-
dominal ultrasound examination, the results of hor-
mone tests were normal, and a hormone-secreting
nature of the tumour was excluded. Open heart surgery
was indicated through median sternotomy (Fig. 5,
panel a, b). The intraoperative findings confirmed the
MRI and coronary CTA results. The tumour was
intrapericardial, attached to the lateral wall of the
pulmonary trunk, 2 cm distal from the commissures
of the pulmonary valve. The tumour did not invade
any other structures of the heart. Complete resection
of the tumour with partial resection of the pulmonary
trunk was performed (Fig. 5, panel c) using cardiopulmo-
nary bypass. The pulmonary trunk was reconstructed with
a round-shaped bovine pericardial patch (Fig. 5, panel b).
The intra- and postoperative course were uneventful.
Fig. 5 The intraoperative images show the complete resection of the tumour and partial resection of the pulmonary trunk (panel a). The pulmonary
trunk was reconstructed using the pericardial patch technique (panel b). The encapsulated giant tumour with the size of 10 × 11 × 4 cm; the arrow
shows the resected part of the pulmonary trunk (panel c)
Fig. 6 Histology: Haematoxylin and eosin, spindle-shaped cells with the “patternless pattern” (panel a, b). Immunohistochemistry: the cells were
positive for vimentin (panel c), CD34 (panel d), CD99 (panel e) and STAT6 (panel f)
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Histological evaluation of the septated, cystic mass re-
vealed tumour cells forming an irregular pattern, the
so-called “patternless pattern” (Fig. 6, panel a, b).
Immunohistochemically, the cells tested positive for
vimentin, CD34, CD99 and STAT6 (Fig. 6, panel c-f )
but negative for keratin (AE1-AE3), CD31 and S100.
Thus, the diagnosis of a primary cardiac solitary fibrous
tumour (SFT) was established. The tumour was classi-
fied as non-malignant because of the lack of increased
mitotic activity, an intact capsule and no sign of vascu-
lar invasion. Regular and long-term clinical and MRI
follow-up were indicated (every 6 months in the first
year, later annually) because of the risk of late local re-
currence. At the 3-year follow-up, the patient had no
symptoms, and MRI did not show recurrence of the
tumour (Fig. 7). The patient’s clinical history is summa-
rized in a timeline, prepared in accordance with CARE
guideline (Additional file 3).
Discussion and conclusions
A solitary fibrous tumour (SFT) is a rare spindle cell
mesenchymal neoplasm that most commonly ori-
ginates from the pleura, but for which extrapleural
anatomic locations have also been reported (e.g.,
intraabdominal, meningeal, extracranial of the head
and neck, and soft tissue SFT) [3, 5]. Primary cardiac
SFTs are extremely rare; so far, there are only 11
cases reported in the English literature [6–16]. Add-
itionally, primary pericardial SFT was mentioned in
Fig. 7 Cine movie MRI images in transverse planes in the diastolic phase before surgery (a-c) and at the three-year follow-up (d-f)
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four publications without any specific information
regarding the exact location, clinical data, patient
symptoms or prognosis [17–20]. The case reports of
primary intrapericardial SFTs reported in the litera-
ture are summarized in Table 1. Based on limited
data about intrapericardial SFTs, it usually affects
middle-aged patients, showing no gender-specific dif-
ference in incidence. Only two of them were diag-
nosed as malignant; in two cases, no information was
available about the malignancy. Other than two
asymptomatic patients with an incidental diagnosis,
all of the reported patients with primary cardiac SFTs
were symptomatic. Symptoms may depend on the ex-
tent and anatomic location of the tumour, most com-
monly dyspnoea, fatigue, chest discomfort/distress,
palpitation, syncope or peripheral oedema.
As a first-line imaging modality, chest X-ray ty-
pically shows marked cardiomegaly, and echocardio-
graphy could verify an intrapericardial mass and
pericardial effusion. MRI can provide additional infor-
mation about the morphology, location and extent of
intrapericardial masses, and it can help to further
characterize the tumour tissue. In general, MRI char-
acteristics of SFT vary because of the altering degree
of vascularity, cystic degeneration, haemorrhage and
necrosis. SFTs usually show intermediate signal intensity
on T1-weighted images and variable signal intensity
on T2-weighted images [2]. In our case, the detailed
assessment of the tumour using various MRI se-
quences and contrast administration showed specific
characteristics of extrapleural SFTs including septated,
patchy, inhomogeneous LGE. Coronary CT angiog-
raphy also has an added value in the precise evalu-
ation of the relation with the coronary arteries.
SFT shows characteristic CD34 expression in 95% of
the cases, and CD99 can also be positive [5]. How-
ever, these markers are not specific. According to re-
cent studies, STAT6 is a highly sensitive and specific
immunohistochemical marker of SFT [21]. Most of
the intrapericardial SFTs confirmed vimentin and
CD34 positivity; specific STAT6 immunostaining was
not yet revealed in intrapericardial SFTs.
Our case confirms the conjecture that intrapericardial
SFTs are typically slow-growing masses because, accord-
ing to the consecutive X-ray images, the intrapericardial
mass started to form at least 7 years ago.
Although the majority of SFTs of the thorax are
benign and are cured by complete resection, 10–20%
are locally aggressive or malignant [22]. Malignant
histology is strongly associated with recurrence, but
some benign SFTs still behave aggressively. The litera-
ture data imply a higher risk for the recurrence of extra-
pleural than that for pleuropulmonary SFT [23]; many
recurrent SFTs do not respond to treatment. This
Table 1 Case reports of primary intrapericardial SFTs reported in the literature supplemented with our case report
Authors Year Age Sex Symptoms Origin Tumour
imaging
Malignancy Follow-up length
(imaging modality)
Immuno-histochemical
marker
1 Bortolotti U et al. [6] 1992 60 M fatigue, chest discomfort,
dyspnoea
AAo, PT X-ray, echo, CT Benign 9 m (X-ray, echo) vimentin+
2 Seqawa D et al. [7] 1995 50 F dyspnoea, palpitation RV X-ray,
CT, MRI
NA 19 m (NA) vimentin+
3 Flemming P et al. [8] 1996 53 F NA LV NA NA died port HTX CD34 +
vimentin +
4 Andreani SM et al. [9] 1998 60 M exertional dyspnoea NA X-ray, CT Benign 4 y (NA) NA
5 Corgnati G et al. [10] 2004 30 M peripheral oedema AAo, PT X-ray, echo
CT, MRI
Benign 18 m (NA) NA
6 Bothe W et al. [11] 2005 39 F palpitation RA echo Benign 12 m (echo) CD34 +
vimentin +
7 Croti UA et al. [12] 2008 5 m M asymptomatic LA X-ray, echo Benign non-CV death after
6 m (NA)
CD34 +
8 Zhao XG et al. [13] 2012 55 M chest distress, dyspnoea RA X-ray, CT Malignant died after surgery CD34 +
9 Taguchi S et al. [14] 2013 49 F asymptomatic LV CT, MRI Malignant NA CD34 +
vimentin +
CD99 +
10 Bianchi G et al. [15] 2013 68 F dyspnoea, fatigue LV echo, CT, MRI Benign 12 m (echo) CD34 +
vimentin +
Bcl2 +
11 Tamenishi A et al. [16] 2013 30 F syncope left PA X-ray, CT Benign 6y (NA) CD34 +
12 Our case 2017 37 F asymptomatic PT X-ray, echo,
CT, MRI
Benign 3y (MRI) CD34 +
vimentin +
CD99 +
STAT6 +
M male, F female, NA no data available, AAo Ascending aorta, PT pulmonary trunk, RA right atrium, LA left atrium, LV left ventricle, PA pulmonary artery, m months,
y years
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underscores the need for continued long-term follow-up
using a high-resolution, non-invasive imaging technique.
In the reported cases, X-ray or echocardiography was used
during follow-up, and only two intrapericardial SFT cases
were reported with a follow-up longer than 2 years [9, 16].
An international registry would be needed to have more
detailed information based on long-term follow-up re-
garding the recurrence tendency of intrapericardial SFTs.
Although intrapericardial SFT is an extremely rare
condition, the slow-growth, considerable size of the
tumour, and its typical MRI appearance can raise the
suspicion of SFT. The “patternless pattern” histo-
pathological finding, vimentin, CD34 and CD99 posi-
tivity and specific STAT6 immunostaining can be
valuable indicators of this rare mesenchymal tumour.
Owing to the high recurrence rate of extrapleural
SFTs, long-term follow-up is crucial, and magnetic
resonance imaging is a reliable method for the early
detection of local recurrence.
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